PHARMARESEARCH BIO Co., Ltd. Logo

PHARMARESEARCH BIO Co., Ltd.

A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.

217950 | KO

Overview

Corporate Details

ISIN(s):
KR7217950005
LEI:
Country:
South Korea
Address:
강원도 강릉시 사임당로 641-3 -, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PHARMARESEARCH BIO Co., Ltd. is a global biopharmaceutical company dedicated to the research, development, manufacturing, and marketing of innovative biological products. A key part of the PharmaResearch group, which specializes in regenerative medicine, the company focuses on creating advanced treatments to improve human health and quality of life. Its R&D pipeline explores novel therapies and biologicals, including toxin-based technologies, contributing to a diverse portfolio that spans pharmaceuticals, medical devices, and cosmetics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-20 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 11.2 KB
2025-04-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-04-23 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.0 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.4 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 94.3 KB
2024-12-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 10.7 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-26 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차)
Korean 8.9 KB
2024-10-29 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.5 KB
2024-10-22 00:00
Legal Proceedings Report
불성실공시법인미지정
Korean 4.6 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all PHARMARESEARCH BIO Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PHARMARESEARCH BIO Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PHARMARESEARCH BIO Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.